Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep575 | Obesity and cardiovascular endocrinology | ECE2015

Can obese patients on antipsychotic medications achieve weight loss in an unmodified general population lifestyle-intervention weight management programme?

Mat Arimin , Ahern Tomas , Breen Cathy , Dunlevy Colin , O'Shea Donal

Background: Many antipsychotics are obesogenic and contribute to significant weight gain with serious implications on patients’ physical and mental well-being. However, patients on antipsychotics are often excluded from unmodified lifestyle-intervention weight management programmes and trials.Objectives: To determine if weight loss is possible for antipsychotic-medicated obese patients when enrolled in an unmodified lifestyle-intervention weight man...

ea0037ep600 | Obesity and cardiovascular endocrinology | ECE2015

Altered sensory motor integration of obese adults

Issartel Johann , Gaul David , Mat Arimin , O'Shea Donal

Introduction: It appears recently that the lack of physical activity might not be a factor for obesity but rather a consequence of perceptual-motor difficulties (D’Hondt et al. 2011). Perception and action are two intertwined processes: perception is a means to action and action is a means to perception. Not being able to perceive correctly visual or auditory information would alter someone’s movement kinematics of any given task. The key question is how do ...

ea0049ep696 | Obesity | ECE2017

GLP-1 therapy and the immune system – can we predict responders from non-responders?

O'Shea Donal , Tobin Laura , Cody Declan , Mat Arimin , Kinlen David , Hogan Andrew

Abstract: Obesity has reached epidemic proportions globally. At least 2.8 million people die each year as a result of being overweight or obese, the biggest burden being obesity-related diseases. Glucagon like peptide 1 (GLP-1) targeted therapies show the greatest potential for intervention and are approved as weight loss agents. However not all patients respond to GLP-1 therapy. Understanding the mechanisms of bodyweight regulation and their role in GLP-1 responders vs. non-r...

ea0037ep574 | Obesity and cardiovascular endocrinology | ECE2015

The prevalence of obesity and metabolic syndrome among inpatients at a Forensic Psychiatric Hospital in the Republic of Ireland

Mat Arimin , Ahern Tomas , Hoare Tracey , McCarran Paul , Kennedy Harry G , O'Shea Donal

Introduction: Patients in secure forensic psychiatric units are at high risk of developing obesity due to complex interplay of factors including antipsychotic medications, restrictions on freedom and poor motivation to healthy lifestyle and physical activities.Aim: To establish the prevalence of obesity and metabolic syndrome (MetS) in a secure forensic psychiatric hospital in the Republic of Ireland (ROI).Methods: We carried out a...